http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2262933-C2
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2001-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98abe185eb49bc6f069bdd088f8adc8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f4664755ec0ed548eafe969ac8a40ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c6cd5b8e345f252c4d85b1cad61ab99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2413db0f4c7780c44e106bd1dca9625 |
publicationDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2262933-C2 |
titleOfInvention | Aspirin-comprising medicinal compositions |
abstract | FIELD: organic chemistry, medicine, pharmacy. n SUBSTANCE: invention relates to a pharmaceutical composition used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism. As active components the composition comprises 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin. Also, invention relates to a set used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism that comprises 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin for simultaneous or successive administration, to using 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or its pharmaceutically acceptable salt and aspirin in preparing a medicinal agent used in prophylaxis or treatment of diseases caused by thrombosis or thromboembolism, to a method for prophylaxis or treatment of diseases caused by thrombosis or thromboembolism. Method involves administration the indicated pharmaceutical composition in pharmacologically active doses in warm-blooded animals and to a method for prophylaxis or treatment of diseases caused by thrombosis or thromboembolism involving the simultaneous or successive administration of this composition in warm-blooded animals. Invention provides effective inhibition of thrombosis due to potentiation of effects and enhanced effectiveness in treatment of diseases caused by thrombosis and thromboembolism. n EFFECT: valuable medicinal properties of compositions. n 20 cl, 2 tbl, 1 dwg, 2 ex |
priorityDate | 2000-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.